CLL Support Association
8,883 members14,197 posts

Evidence-vs-access-addressing-the-balance-in-assessing-new-cancer-drugs?

Evidence-vs-access-addressing-the-balance-in-assessing-new-cancer-drugs?

An interesting article on the dilemma faced by the approving authorities like Nice. Approving drugs that don't work well takes funds away from those that do work well.

icr.ac.uk/blogs/science-tal...

You may also like...